Veterinary Medicines

EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους

Authorised
  • Canine distemper virus, strain BA5, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parainfluenza virus 2, Inactivated
Download as PDF

Identifikazzjoni tal-prodott

Isem tal-mediċina:
EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους
Sustanza attiva:
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
  • Użu għal taħt il-ġilda

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    10000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    316.22
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    79.43
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    50.12
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
Forma farmaċewtika:
  • Trab u solvent għal suspensjoni għall-injezzjoni
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QI07AI02
Status legali tal-provvista:
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Greece
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Bażi ġuridika tal-awtorizzazzjoni tal-prodott:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Boehringer Ingelheim Animal Health France
Awtorità responsabbli:
  • National Organization For Medicines
Numru tal-awtorizzazzjoni:
  • 38630/27-04-2017/K-0225001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."